STAQ Pharma has filed a notice of an exempt offering of securities to raise $30,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, STAQ Pharma is raising up to $30,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Joseph Bagan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About STAQ Pharma
SAFETY Lives are at stake here. Pediatric concentrations. Created specifically for pediatric patients. Developed with guidance from Childrens Hospital Colorado. And adult concentrations for adults. Because every surgical patient deserves the right drug in the right concentration and volume, packaged for safe and effective administration at the right time. TRANSPARENCY Lets be clear. Video feeds with remote access. Proactively-shared 483s and corrective actions. Final product testing on every batch. Designed and built to comply with FDA regulations as a cGMP facility, theres nothing to hide. AVAILABILITY Say goodbye to shortage issues. Onsite production of non-sterile to sterile solutions. And sterile-to-sterile repackaging. Inventory systems to forecast needs and proactively provide partners with critical product. Capacity to produce up to 30,000 pre-filled syringes a day at full build out. Centrally located in Denver, Colorado, and Columbus, Ohio, STAQ Pharma can quickly access and support hospitals across the United States. QUALITY Setting the bar higher. Independent testing analysis to measure stability, sterility, potency and endotoxins on every batch. Integrated robotics. State-of-the-art manufacturing and inspection equipment. With more than 5,000 square feet of highly-automated cleanroom space and an extensive Quality Management System operation, the STAQ facility is designed to meet the highest of industry standards.
To learn more about STAQ Pharma, visit http://staqpharma.com/
STAQ Pharma Linkedin Page: https://www.linkedin.com/company/staq-pharma/
Contact:
Joseph Bagan, Chief Executive Officer
720-961-2720
https://www.linkedin.com/in/joe-bagan-8b285851/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.